| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700853 | European Journal of Surgical Oncology (EJSO) | 2017 | 6 Pages |
Abstract
The risk of a needle tract metastasis after core needle biopsy for retroperitoneal sarcoma is very low but not zero. The safest method seems a trans-retroperitoneal approach with a co-axial technique. Local recurrence rate is not altered after doing a core needle biopsy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
W.J. Van Houdt, A.M. Schrijver, R.B. Cohen-Hallaleh, N. Memos, N. Fotiadis, M.J. Smith, A.J. Hayes, F. Van Coevorden, D.C. Strauss,